Research Article| Volume 40, ISSUE 6, P716-727, November 2022

Download started.


Melanotic lupus erythematosus: A review of a newly described clinical form of chronic cutaneous lupus erythematosus


      Melanotic lupus erythematosus (LE) is a rare and newly described form of chronic cutaneous LE. In this review, we have synthesized existing data on the epidemiologic, clinical, histologic, and immunologic features of melanotic LE. We performed a systematic review using PubMed to identify eligible publications. Eight contributions fulfilled the eligibility criteria and were included in the qualitative synthesis. Twenty-eight patients with a mean age of 57.7 years were included. All patients had medium to dark skin phototypes. The lesions presented either as solitary and localized, poorly limited, round, or oval patches (50%) or as a more diffuse or generalized, sometimes reticulated, hyperpigmentation (50%). Patients diagnosed with systemic LE accounted for 14% of included cases. Antinuclear antibodies were positive in 10.7% of cases. Hydroxychloroquine and topical steroids were the most commonly used treatments. Complete resolution of the lesions was noted in 27.27% of cases. No patient experienced atrophy, destruction, or deformity of the skin. Melanotic LE appears to affect mainly patients with dark phototypes. It is characterized by late age at the onset of disease and an overall good prognosis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Petersen MP
        • Möller S
        • Bygum A
        • et al.
        Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.
        Lupus. 2018; 27: 1424-1430
        • Kuhn A
        • Ruland V
        • Bonsmann G.
        Cutaneous lupus erythematosus: update of therapeutic options part II.
        J Am Acad Dermatol. 2011; 65: e195-e213
        • Wollina U
        • Hansel G.
        The use of topical calcineurin inhibitors in lupus erythematosus: an overview.
        J Eur Acad Dermatol Venereol. 2008; 22: 1-6
        • Gilliam JN
        • Sontheimer RD.
        Distinctive cutaneous subsets in the spectrum of lupus erythematosus.
        J Am Acad Dermatol. 1981; 4: 471-475
        • Litaiem N
        • Chaker H
        • Zeglaoui F.
        sQUIZ your knowledge! A rare aetiology of diffuse facial hyperpigmentation.
        Eur J Dermatol. 2020; 30: 641-643
        • Khullar G
        • De D
        • Narang T
        • et al.
        Pigmented macular variant of chronic cutaneous lupus erythematosus: an under-recognized subset in dark skin.
        Clin Exp Dermatol. 2017; 42: 793-795
        • Pramatarov KD.
        Chronic cutaneous lupus erythematosus: clinical spectrum.
        Clin Dermatol. 2004; 22: 113-120
        • Calleja Algarra A
        • Aragón Miguel R
        • Prieto Barrios M
        • et al.
        Generalized facial pigmentation: An uncommon presentation of cutaneous lupus erythematosus.
        Indian J Dermatol Venereol Leprol. 2020; 86: 431-435
        • Patel P
        • Werth V.
        Cutaneous lupus erythematosus: a review.
        Dermatol Clin. 2002; 20: 373-385
        • Azrielant S
        • Ellenbogen E
        • Peled A
        • et al.
        Diffuse facial hyperpigmentation as a presenting sign of lupus erythematosus: three cases and review of the literature.
        Case Rep Dermatol. 2021; 13: 263-270
      1. Gupta S, Rao R: An unusual cause of facial melanosis: a wolf in disguise! [e-pub ahead of print]. Int J Dermatol. doi:10.1111/ijd.14641, accessed Month D, YYYY.

        • Sharma RK
        • Sharma R.
        Generalized pigmented lupus erythematosus: a new clinical subset?.
        Pigmentary Disorders. 2016; 3: 237
        • Dogruk Kacar S
        • Ozuguz P
        • Yavaş B
        • et al.
        Melanotic lupus erythematosus: a rare variant of discoid lupus erythematosus.
        TURKDERM. 2015; 49: 75-77
        • Boyd AS.
        Localized chronic cutaneous lupus erythematosus masquerading as pigmented lesions: a new clinical subset?.
        Lupus. 2006; 15: 292-295
        • George R
        • Mathai R
        • Kurian S.
        Cutaneous lupus erythematosus in India: immunofluorescence profile.
        Int J Dermatol. 1992; 31: 265-269
        • Kapadia N
        • Haroon TS.
        Cutaneous manifestations of systemic lupus erythematosus: study from Lahore, Pakistan.
        Int J Dermatol. 1996; 35: 408-409
        • Dubois EL
        • Tuffanelli DL.
        Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 cases.
        JAMA. 1964; 190: 104-111
        • Patel AB
        • Kubba R
        • Kubba A.
        Clinicopathological correlation of acquired hypopigmentary disorders.
        Indian J Dermatol Venereol Leprol. 2013; 79: 376-382
        • de Berker D
        • Dissaneyeka M
        • Burge S.
        The sequelae of chronic cutaneous lupus erythematosus.
        Lupus. 1992; 1: 181-186
        • Grönhagen CM
        • Fored CM
        • Granath F
        • et al.
        Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
        Br J Dermatol. 2011; 164: 1335-1341
        • Durosaro O
        • Davis MD
        • Reed KB
        • et al.
        Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study.
        Arch Dermatol. 2009; 145: 249-253
        • Craig WY
        • Ledue TB
        • Johnson AM
        • et al.
        The distribution of antinuclear antibody titers in “normal” children and adults.
        J Rheumatol. 1999; 26: 914-919
        • Callen JP.
        Chronic cutaneous lupus erythematosus: clinical, laboratory, therapeutic, and prognostic examination of 62 patients.
        Arch Dermatol. 1982; 118: 412-416